Profits and Prophets: May
From May 2005
Community Comments
Possibilities Abound for Ceronix, IDW and ThermoGenesis
By Art Garcia
ThermoGenesis Headed For First Profitable Year
After another loss, equal to 13 cents per share in its fiscal year ended last June 30, ThermoGenesis Corp. (Nasdaq: KOOL; www.thermogenesis.com) this year may end up in the black for the first time, confirms Philip Coelho, chairman and CEO.
The consensus of analysts’ estimates is that the Rancho Cordova manufacturer of cryogenic systems for cord blood banks — and one of the emerging companies chosen in last year’s Prosper “Baby Blue Chip” poll (see story, page 23 this issue) — will log its first profits, registering about 21 cents per share.
“That seems to be high,” Coelho tells Prosper. “But I believe that by the end of the current fiscal year, we will be profitable. Over the next 12 months there will be products currently in clinical trials that should be released to start providing revenues.
“We have a variety of new products coming to market, and that should boost revenues and boost margins,” he adds. “By the end of the fiscal year we should be at a run rate that is profitable.”
Continued...
The Magazine
Site Links
Prosper Plus +
- Get Prosper Plus to receive e-mail alerts, special event invites, and content that interests you.
Community
- Join the Community and start participating. It's fast. It's easy. It's free.
Advertise on this site! Show your support for the Prosper Network and reach influential thought leaders and web users like yourself. Contact us to find out how.
© 2004-2007 Prosper Media, LLC. All Rights Reserved. Terms of Use | Privacy Policy
The materials on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Prosper Media, LLC.
Community Comments